Kymera Therapeutics (KYMR) Asset Utilization Ratio (2020 - 2025)
Kymera Therapeutics (KYMR) has disclosed Asset Utilization Ratio for 6 consecutive years, with 0.03 as the latest value for Q4 2025.
- On a quarterly basis, Asset Utilization Ratio fell 41.06% to 0.03 in Q4 2025 year-over-year; TTM through Dec 2025 was 0.03, a 41.06% decrease, with the full-year FY2025 number at 0.03, down 52.43% from a year prior.
- Asset Utilization Ratio was 0.03 for Q4 2025 at Kymera Therapeutics, down from 0.04 in the prior quarter.
- In the past five years, Asset Utilization Ratio ranged from a high of 0.14 in Q2 2021 to a low of 0.03 in Q4 2025.
- A 5-year average of 0.09 and a median of 0.09 in 2023 define the central range for Asset Utilization Ratio.
- Peak YoY movement for Asset Utilization Ratio: soared 84.72% in 2023, then crashed 66.43% in 2024.
- Kymera Therapeutics' Asset Utilization Ratio stood at 0.12 in 2021, then crashed by 35.36% to 0.08 in 2022, then skyrocketed by 84.72% to 0.14 in 2023, then plummeted by 66.43% to 0.05 in 2024, then tumbled by 41.06% to 0.03 in 2025.
- Per Business Quant, the three most recent readings for KYMR's Asset Utilization Ratio are 0.03 (Q4 2025), 0.04 (Q3 2025), and 0.04 (Q2 2025).